baber/WOPTO huggingface dataset:
Patent NZ-521524-A (NZ)
Title: 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
Inventor: VAILLANCOURT VALERIE A
IPC: C07D237/28
Filed: 2001-03-15
Abstract: Cinnoline compounds of formula (I) that inhibit viral DNA polymerases, and the use thereof as antiviral agents.
Patent NZ-525208-A (NZ)
Title: Seed treatment with combinations of pyrethrins/pyrethroids and clothianidin
Inventor: ASRAR JAWED
IPC: A01N37/44
Filed: 2001-10-02
Abstract: A method of preventing damage to the seed and/or shoots and foliage of a plant by a pest includes treating the seed from which the plant grows with a composition that includes a combination of clothianidin and at least one pyrethrin or synthetic pyrethroid. The treatment is applied to the unsown seed and is effective to protect seed, shoots and foliage from damage, with no need for subsequent application to the plant. In another embodiment, the seed is a transgenic seed having at least one heterologous gene encoding for the expression of a protein having pesticidal activity against a first pest and the composition has activity against at least one second pest. Treated seeds are also provided.
Patent NZ-525344-A (NZ)
Title: Removable deep set drop-in anchor
Inventor: WARMOLTS JEFFREY C
IPC: F16B13/06
Filed: 2003-04-16
Abstract: The drop-in anchor (10) comprises a sleeve (12) having a threaded region (22) having an internal thread formed therein and a split region (24) having at least two longitudinal channels (40b, 40c). The split region (24) has inwardly tapered inner walls. There is also a plug (14) configured for engagement with the split region. A shank (16) having threaded portion (44) and a through bore (18) is provided to engage the threaded region of the sleeve. A setting member (20) is configured for insertion into the shank bore and for engaging the plug top surface. When a force is exerted on the setting member, the plug is driven into the sleeve split region to urge the split region sections axially outward.
Patent NZ-525470-A (NZ)
Title: A dispenser for filamentary material
Inventor: KERNOT CHRISTOPHER JOSEPH
IPC: A61C15/04
Filed: 2003-04-23
Abstract: A dispenser comprising a substantially closed housing having a pair of oppositely disposed substantially planar wall portions, substantially parallel and spaced apart by less than 6mm. A dispensing area, a supply of filamentary material is disposed within said housing, a moveable cover connected with said housing to be moveable between a first operating condition, and a second operating condition, wherein said cover when in said first operating condition encloses said dispensing area, and said cover when in said second operating condition exposes said dispensing area.
Patent NZ-530024-A (NZ)
Title: HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
Inventor: CANON-KOCH STACIE S
IPC: A61K38/04
Filed: 2002-06-11
Abstract: Compounds of formula (I) that advantageously inhibit or block the biological activity of the HIV protease are disclosed, wherein the formula variables are as defined in the specification. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.
Patent NZ-531060-A (NZ)
Title: Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
Inventor: DAVIS HARRY R
IPC: C07D205/08
Filed: 2002-09-19
Abstract: Disclosed is a use of (a) at least one sterol absorption inhibitor or at least one 5alpha-stanol absorption inhibitor and (b) at least one cholesterol biosynthesis inhibitor in the preparation of a medicament for simultaneous, separate or sequential use for treating vascular inflammation in a subject, having a blood level of c-reactive protein of greater than about 0.4 mg/dL.
Patent NZ-531335-A (NZ)
Title: Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
Inventor: JIANG ZHIWEI
IPC: A61K47/30
Filed: 2002-07-31
Abstract: Disclosed are pharmaceutical compositions comprising a therapeutically effective amount of Beta-lapachone, or a derivative or analogue thereof, and a pharmaceutically acceptable water-solubilising carrier molecule, wherein said molecule is selected from the group consisting of Poloxamer, Povidone K17, Povidone K12, Tween 80, polyethylene glycol (PEG) 400, propylene glycol, Trappsol, alpha-cyclodextrin or analogues thereof, beta-cyclodextrin or analogues thereof, and gamma-cyclodextrin or analogues thereof. These compositions are utilised in the preparation of medicaments suitable in the treatment of cancer and dermatologic conditions, particularly psoriasis.
Patent NZ-531983-A (NZ)
Title: Prediction of structural properties and warp propensity of lumber or veneer from log taper
Inventor: FLOYD STANLEY L
IPC: G06F15/00
Filed: 2002-09-30
Abstract: The taper of a log is measured, and the taper measurement used to estimate the structural properties or warp propensity of lumber or veneer that might be produced from the log. The estimate is based on a predetermined correlation between taper and the properties to be predicted. The correlation is produced from a regression equation derived from sampling the properties of lumber or veneer cut from logs that are a representative sample of the log type it is desired to measure; age, growth conditions and species being the major similarity factors of the sample. (62) Divided out of 521671
Patent NZ-532374-A (NZ)
Title: Diagnostic method for typing TSEs in an infected animal with an antibody that recognises specific types of TSE
Inventor: STACK MICHAEL JAMES
IPC: G01N27/447
Filed: 2002-10-23
Abstract: A method for typing a strain of a transmissible spongiform encephalopathy (TSE) in an infected animal, said method comprising: a) separating a sample of abnormal prion protein on the basis of molecular weight and/or glycoform ratios, and detecting the separated forms; b) detecting in the sample the presence of a peptide sequence, wherein the presence of said peptide sequence within abnormal prion protein is capable of distinguishing a particular strain of TSE from others, and c) using the results of (a) and (b) to determine the type of TSE strain present in the sample. The method may be used in particular to distinguish BSE from scrapie in sheep.
Patent NZ-540461-A (NZ)
Title: Pesticidal sulphonylaminopyrazoles for controlling arthropods and helminths
Inventor: DOLLER UWE
IPC: A01N43/713
Filed: 2003-11-12
Abstract: 5-Substituted-sulfonylaminopyrazole derivatives of formula (I) or salts thereof: wherein the variables are as defined in the specification, pesticidal compositions thereof, processes for their preparation, and their use for the control of pests, such as arthropods (insects and arachnids) and helminths (nematodes) are disclosed.
Patent NZ-541591-A (NZ)
Title: Method for the treatment of cerebral ischaemia and use of erythropodietin or erythropoietin derivatives for the treatment of cerebral ischaemia
Inventor: EHRENREICH HANNELORE
IPC: A61P9/10
Filed: 1999-12-13
Abstract: Disclosed is the use of erythropoietin (EPO) in the preparation of a medicament formulated for peripheral application for treating cerebral ischaemia in a mammal in need thereof.
Patent NZ-543864-A (NZ)
Title: Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
Inventor: BALZARINI JAN MARIE RENE
IPC: A61K31/505
Filed: 2004-06-16
Abstract: Disclosed are antiviral nucleotide analogs of formula (I) wherein: R1 is H, amino, or methylsulfanyl; R2 is H, methyl, halo, -N(R5)2, hydroxy, or protected hydroxy; R3 is independently methyl, hydroxymethyl, halomethyl, or protected hydroxymethyl; R4 is selected from alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, -CH2OH, -CH2OR5, -CH2C(O)R5, -CH2R6, ûCH2OC(O)R5, ûCH2OC(O)CH(R7)(NHR8), ûCH2NR9R10, -CH2CN, -CO2R5, ûCH2CH2OH, -CH2CH2OR5, -CH2CH2OC(O)R-5, -CH2CH2OC(O)CH(R7)(NHR8), -CH2SH, -C(O)H, -CH2CO2R9, -CH2SO3H, -CH2CH2SO3H, -CH2CH2PO3H2, -CH2CH2OCH2PO3H2, -CH2OPO3H2, -OCH2PO3H2, -OH, ûOR10, -NH2, -NR11R12, -SH, ûSR5, -SCN, -N3, -CN, ûCONR11R-12, -CH2CONR11R12, -NHOH, ûNHOR5, -NO, -NO2, ûNHNR11R12, 2-halovinyl, 3,3,3-trifluoropropenyl, 2-(alkoxycarbonyl)ethenyl, 2-carboxyethenyl, 2-cyanoethenyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, 2-haloethyl, and -CH2N3; X independently is oxygen, sulfur, or a bond; Z independently is hydroxy, an ester or amide; and the remainder of the substituents are as described in the specification.
Patent NZ-545453-A (NZ)
Title: Pharmaceutical formulation comprising a 2-thiopyrimidine-4-one derivative coated with an enteric polymer
Inventor: VAN SCHIE DIRK MARINUS JOHANNE
IPC: A61P9/10
Filed: 2004-08-31
Abstract: Disclosed is a pharmaceutical formulation comprising a core which includes a compound of formula (I), wherein the substituents are as defined in the specification, and a casing which comprises an enteric polymer.
Patent NZ-545864-A (NZ)
Title: Benzimidazole derivates: preparation and pharmaceutical applications
Inventor: CHEN DIZHONG
IPC: C07D235/10
Filed: 2004-09-21
Abstract: Disclosed is a compound of the formula (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are disclosed within the specification. Also disclosed is the use of a compound of the formula (I) in the preparation of a medicament for the treatment of a disorder caused by, associated with or accompanied by disruptions of cell proliferation and/or angiogenesis, a disease associated with deacetylase activity, a neurodegenerative disorder or an inflammatory disease and/or immune system disorder.
Patent NZ-560511-A (NZ)
Title: Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
Inventor: CORREALE PIERPAOLO
IPC: C12N15/63
Filed: 2006-02-15
Abstract: Provided is a multiepitope peptide, for medical use, consisting of amino acids 1 to 9; amino acids 10 to 18; and amino acids 19 to 27 of a specified sequence, wherein the groups can be combined in any order. Further provided is the peptide consisting in the sequence YMIAHITGLFLDSLGFSTTLGDAHIYL. Further provided are corresponding expression vectors and methods of obtaining in vitro cytotoxic T lymphocytes using the materials and use of such lymphocytes in immunotherapy.
Patent NZ-564901-A (NZ)
Title: Mixing system for a portable media device
Inventor: SEIL OLIVER DUNCAN
Filed: 2008-01-07
Abstract: A mixer capable of receiving an input signal from a media system and producing an output signal for a signal output device and a portable media device is provided, which includes an input jack, an interface, an output jack and a device operating system. The input jack is configured to receive and be electrically coupled to a component of the media system, where the component is capable of producing the input signal. The interface is configured to electrically couple to the portable media device and to allow the portable media device to record the output signal. The output jack is configured to receive and be electrically coupled to the signal output device, where the signal output device is capable of receiving the output signal. The device operating system is configured to receive one or more instructions for controlling at least one function of the mixer, where the instructions are entered at the portable media device by a user and routed via the interface to the device operating system when the portable media device is electrically coupled to the interface.
Patent NZ-566515-A (NZ)
Title: Post driver mountable to three point linkage
Inventor: FAIRBROTHER JAMES ERNEST
IPC: A01B59/043
Filed: 2008-03-07
Abstract: A post or pile driver that is to be supported by a three point linkage from a vehicle includes a post driver 41 with a mast, a frame 43, 44, 45, 46 carrying a controllable carriage 35, and an extendable assembly 42 from the carriage that supports the mast. An extendable link 37 extends from the mast to the upper linkage 39 of the three point linkage, and lower links 36 extend from the frame to each of the lower linkages of the three point linkage. The carriage can be moved laterally on the frame to move the mast laterally and the movement of the extendable assembly moves the mast toward or away from the frame as well as allowing the mast to pivot both laterally and toward and away.
Patent NZ-567205-A (NZ)
Title: Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
Inventor: SCHOENAFINGER KARL
IPC: A61K31/433
Filed: 2006-09-26
Abstract: The disclosure relates to cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides of the formula (I) and to their physiologically acceptable salts showing PPARdelta, PPARalpha and PPARgamma agonist activity, in which the radicals are as defined in the specification, and pharmaceutical compositions comprising these compounds and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.
Patent NZ-567796-A (NZ)
Title: A sliding panel operation mechanism in which the panel is released by pushing on it along the alignment plane
Inventor: BERTRAM GRAEME OWEN
Filed: 2008-04-28
Abstract: A method of operating a panel system including a moveable panel 3 and an opening 6, the method characterised by the steps of: a) aligning the panel 3 with respect to the opening 6 in an alignment plane 4 so that the panel 3 is capable of moving across the opening 6 in the alignment plane, and b) positioning a panel release mechanism 8 such that a user pushing on the panel along the alignment plane 4 causes the panel release mechanism 8 to release the panel 3 from a fixed position within the panel system.
Patent NZ-570486-A (NZ)
Title: Nasal devices including dilation and user comminication and methods if using same
Inventor: FENTON GUSTAV R
IPC: A61M29/00
Filed: 2002-12-27
Abstract: A nasal dilator device includes an elongated flexible body including a sealed chamber containing a fluid such as air and an adhesive material disposed on the flexible body for securing the flexible body onto nasal surfaces of a user.
Patent NZ-577169-A (NZ)
Title: System and method for remote monitoring and/or management of infusion therapies
Inventor: HYMAN OSCAR E
IPC: G06Q50/00
Filed: 2007-11-20
Abstract: A system for monitoring and/or managing infusion therapy over a network is disclosed. The system comprises at least one infusion pump, remotely located user interface device, and server. The infusion pump delivers an infusion therapy and is coupled to an apparatus configured to query a patient regarding whether the patient may be experiencing an adverse reaction to the infusion therapy. The at least one remotely located user interface device monitors and controls the infusion pump, and the at least one user interface device is configured to monitor the patient's response to the adverse reaction query. The at least one server is connected to the user interface device for monitoring and controlling the infusion pump such that the user interface device and the one infusion pump communicate via the network through the at least one server.
Patent NZ-583808-A (NZ)
Title: Crystalline forms of (s) -ethyl 2-amino-3- (4- (2 -amino- 6- ( (r) -1- (4-chloro-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
Inventor: BEDNARZ MARK S
IPC: C07D403/12
Filed: 2008-09-25
Abstract: Disclosed is a crystalline (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3- methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4 yl)phenyl)propanoate or a pharmaceutically acceptable salt thereof. Also disclosed is the use of the compound for the manufacture of a medicament for treating, preventing or managing a disease or disorder mediated by peripheral serotonin.
Patent NZ-584278-A (NZ)
Title: Sdf-1-based glycosaminoglycan antagonists and methods of using same
Inventor: KUNGL ANDREAS
IPC: A61K38/19
Filed: 2008-10-23
Abstract: Disclosed are mutants of human stromal cell-derived factor-1 which exhibit increased glycosaminoglycan (GAG) binding affinity and inhibited or down-regulated GPCR activity compared to wild type SDF-1, methods for producing these mutants and to their use for preparing medicaments for the treatment of cancer.
Patent NZ-586818-A (NZ)
Title: Methods and related compositions for reduction of fat
Inventor: KOLODNEY MICHAEL S
IPC: A61Q19/06
Filed: 2005-05-19
Abstract: Disclosed is a composition consisting essentially of one bile acid or a salt thereof in an amount of at least about 0.2 percent weight/volume (w/v) (4.8 mM), a phosphotidylcholine in an amount that is less than that of the bile acid, and a pharmaceutically acceptable excipient. Also disclosed is the use of the composition for the manufacture of a medicament for the non-surgical removal of localised fat accumulation. Examples of prefered bile acids are deoxycholic acid and chenodeoxycholic acid.
Patent NZ-595046-A (NZ)
Title: Compositions and methods for extended therapy with aminopyridines
Inventor: BLIGHT ANDREW R
IPC: A61K31/4409
Filed: 2010-02-11
Abstract: 595046 Disclosed herein is the use of a sustained release composition of 4-aminopyridine for the manufacture of a medicament for sustaining an improvement in walking in a multiple sclerosis patient for an extended period of time, said medicament to be administered twice daily in a dose of 10 milligrams of 4-aminopyridine for the extended period of time, wherein the extended period of time is at least 1 year.
Patent NZ-620723-A (NZ)
Title: Sealing mechanism and method for drop cable splice enclosures
Inventor: GWILLIM ROBERT H
IPC: H02G15/16
Filed: 2012-07-16
Abstract: A sealing mechanism for a drop cable splice enclosure is disclosed. The enclosure includes a base (22) having an entry hole (44) for receiving a drop cable inserted through a compression grommet assembly, from outside the enclosure. The cable can be prepared for splicing, outside the enclosure. The grommet assembly (and the optionally prepared cable) are inserted into the entry hole, from outside the enclosure. The assembly includes upper and lower pressure plates (26, 28), a compressible grommet (24) between them, and an adjustment mechanism to apply a compression force to the grommet. The grommet assembly is rotatable to lock it in a keyed section in the entry hole. The adjustment mechanism is then tightened, from outside the enclosure, to compress the grommet between the pressure plates, which seals the grommet in the enclosure base, at the same time sealing the cable in the passageway through the grommet.
Patent NZ-624453-A (NZ)
Title: 2-thiopyrimidinones
Inventor: DOW ROBERT LEE
IPC: C07D471/04
Filed: 2012-10-28
Abstract: Disclosed herein are myeloperoxidase inhibitors of formula I where the substituents are as defined herein, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, cardiovascular conditions. Specific examples of the compounds of formula I include 6-(2,4-dimethoxyphenyl)-1-(2-hydroxyethyl)-2-thioxo-2,3-dihydropyrimidin-4(1H)-one, 2-(6-(2,5-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide and N-(2-aminoethyl)-2-[6-(2,4-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl]acetamide.
Patent NZ-625791-A (NZ)
Title: Led lighting apparatus
Inventor: KIM DUK YONG
IPC: F21V17/02
Filed: 2012-11-09
Abstract: The present invention relates to an LED lighting apparatus. The LED lighting apparatus includes a power source housing (10) provided with a power supply unit therein and having a plurality of connection parts disposed on a bottom surface. The apparatus also includes a ring-shaped frame (20) on which a connection frame coupled to the connection parts of the power source housing (10) is disposed. The ring-shaped frame (20) accommodating a transmission line through which power from the power supply unit is supplied. A plurality of lighting part housings (30) coupled to a lower portion of the frame (20) to receive the power through the transmission line, thereby applying the power to the accommodated LED (32) to emit light. Thus, the lighting part housings (30) of the LED lighting apparatus may be changed in quantity and position to vary light distribution and luminance.
Patent NZ-630091-A (NZ)
Title: Immunofluorescence and fluorescent-based nucleic acid analysis on a single sample
Inventor: SEPPO ANTTI E
IPC: G01N33/574
Filed: 2013-03-21
Abstract: Disclosed is a method for providing a composite image of a single biological sample. The method comprises the steps of: (1) generating a first image of the biological sample, (2) generating a second image of the biological sample and (3) generating a composite image that provides the relative location of both the target protein and the target nucleic acid. The step of generating a first image of the biological sample comprises the sub-steps of: a. contacting the sample on a solid support with a first binder for a target protein; b. staining the sample with a fluorescent marker that provides morphological information; c. detecting, by fluorescence, signals from the first binder and the fluorescent marker; d. generating the first image of at least part of the sample from the detected fluorescent signals. The step of generating a second image of the biological sample comprises the sub-steps of a. contacting the same sample from step (1) with a probe for each of at least one target nucleic acid sequence thus hybridizing the probes with the target nucleic acid sequence; b. optionally, staining the sample with the fluorescent marker; c. detecting, by fluorescence, signals from the probes for each of the target nucleic acid sequences and the fluorescent marker; and d. generating the second image of at least part of the sample from the detected fluorescent signal.
Patent NZ-700760-A (NZ)
Title: 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
Inventor: HO WEN-BIN
IPC: C07D409/12
Filed: 2013-03-08
Abstract: The present invention relates to novel compounds of formula (I), and compositions capable of inhibiting PHD1 enzyme activity selectively over other isoforms, for example, PHD2 and/or PHD3 enzymes. The invention also relates to compounds of formula (I) for use in disorders such as muscle degeneration, colitis, IBD, and certain ischemias.
Patent NZ-700842-A (NZ)
Title: Frozen noodles and production method therefor
Inventor: WATANABE TAKENORI
IPC: A23L29/269
Filed: 2013-04-05
Abstract: Provided is a production method for frozen noodles comprising: a step in which a composition that contains xantham gum and that has a viscosity of 30-2000 mPa·s at 60 °C is affixed to cooked noodles, said noodles being obtained by cooking raw noodles produced using a noodle production method that involves rolling; and a step in which the noodles to which the composition has been affixed are frozen.
Patent NZ-707874-A (NZ)
Title: A method for manufacturing biodegradable packaging material, biodegradable packaging material, and packages and containers made thereof
Inventor: NEVALAINEN KIMMO
IPC: D21H19/28
Filed: 2013-10-23
Abstract: The invention provides a biodegradable packaging material, a method of manufacturing the same, as well as products made of the material. There is coextruded onto a fibrous substrate (1) a multilayer coating comprising innermost and outermost layers (2, 4) of a blend comprising 20-95 wt-% of a higher melt index polylactide and 5-80 wt-% of another biodegradable polymer such as polybutylene succinate, and a middle layer (3) containing a lower melt index polylactide alone. The goal is to increase machine speed in coextrusion while maintaining good adhesiveness to the substrate and good heat-sealability of the coating. The products include disposable drinking cups and board trays, as well as sealed carton packages for solids and liquids.